Results 71 to 80 of about 1,899,013 (161)
Case report of a transcatheter tricuspid valve-in-valve replacement [PDF]
Transcatheter valve implantations in the tricuspid position are infrequent. We report a case of an Edwards SAPIEN 3 (S3) implantation in the tricuspid position as a transcatheter valve-in-valve procedure in a 12-year-old patient deemed at high risk for ...
Pillay, DN, Brown, SC, Buys, DG
core +1 more source
Transcatheter Tricuspid Valve Clinical Trials: Incomplete Data and FDA-Approved Devices
Each reviewed trial of transcatheter tricuspid valve intervention demonstrated clinically meaningful improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ)-defined quality of life and favorable right ventricular remodeling.
Deborah Furman, MD, Brian Whisenant, MD
doaj +1 more source
With explosive growth in the field of transcatheter therapies in recent years, transcatheter valve-in-valve implantation has rapidly emerged as a viable, low-risk alternative to high-risk redo surgical interventions.
Cabalka, Allison K +6 more
core +1 more source
In an independent multicenter cohort of 951 patients undergoing echocardiography, a deep learning model analyzing an 8‐s heart sound and ECG recording detected moderate‐or‐greater aortic stenosis with 92.9% sensitivity and 87.9% specificity. This approach may support the decision to refer patients from auscultation to echocardiography.
Shumpei Saito +23 more
wiley +1 more source
Using two nationwide prospective Chinese cohorts totaling nearly 11,000 patients with significant mitral regurgitation, we developed and externally validated a CatBoost‐based machine learning model for all‐cause mortality prediction. The model achieved AUCs of 0.783 internally and 0.703 externally, outperforming the Cox model, MitraScore, and EuroSCORE
Yuzhe Yin +19 more
wiley +1 more source
Transcatheter tricuspid valve replacement: will it prevail?
Severe tricuspid regurgitation (TR) is a prevalent and challenging condition associated with poor survival outcomes and significant morbidity. Medical therapy alone often fails to provide adequate symptom relief, and stand-alone surgical intervention is ...
Xiling Zhang +22 more
doaj +1 more source
ABSTRACT Pulmonary hypertension (PH) is common in patients undergoing transcatheter mitral edge‐to‐edge repair (M‐TEER) and is an established determinant of adverse outcomes after intervention. Importantly, persistent PH after technically successful M‐TEER remains associated with ongoing symptoms, right ventricular dysfunction and poor prognosis, yet ...
Xiang Chen +7 more
wiley +1 more source
Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly. [PDF]
We sought to describe the acute results and short- to medium-term durability of transcatheter tricuspid valve-in-valve (TVIV) implantation within surgical bioprostheses among patients with Ebstein anomaly (EA).
Taggart, Nathaniel W +59 more
core +1 more source
Isolated tricuspid regurgitation (TR) represents a significant yet understudied cardiac condition, primarily arising from structural valve anomalies or secondary to right ventricular (RV) dysfunction.
Mohammed Shaban +5 more
doaj +1 more source

